Aligos Therapeutics
ALGS
ALGS
35 hedge funds and large institutions have $19.2M invested in Aligos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9K | |
| 2 | +$11.9K | |
| 3 | +$7.51K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.96K |
Top Sellers
| 1 | -$146K | |
| 2 | -$81.6K | |
| 3 | -$69.2K | |
| 4 |
Millennium Management
New York
|
-$62.8K |
| 5 |
Two Sigma Advisers
New York
|
-$50.9K |